MBX Biosciences, Inc.
MBX • XNAS
MBX Biosciences, Inc. is a pharmaceutical preparations company trading on XNAS, led by CEO Peter Kent Hawryluk, with a market cap of $1.4B.
CEOPeter Kent Hawryluk
Next Earnings
Upcoming earnings announcement for MBX Biosciences, Inc.
Date
Monday, May 11, 2026 (in a month)
Timing
Before Market Open (8:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.58
Earnings History
Past 6 earnings reports for MBX Biosciences, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 12, 2026 | Q4 2025 | -$0.49Est: -$0.61 | +19.7% | - | — |  10-K |
| Nov 6, 2025 | Q3 2025 | -$0.63Est: -$0.69 | +8.7% | - | — | 10-Q |
| Aug 7, 2025 | Q2 2025 | -$0.58Est: -$0.76 | +23.7% | - | — | 10-Q |
| May 12, 2025 | Q1 2025 | -$0.71Est: -$0.77 | +7.8% | - | — | 10-Q |
| Mar 17, 2025 | Q4 2024 | -$0.47Est: -$0.58 | +19.0% | - | — | 10-K |
| Nov 7, 2024 | Q3 2024 | -$2.78 | — | - | — | 10-Q |